Cancer Antigen 242
| Catalog number: | B2012232 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 kU |
| Molecular Weight or Concentration: | 25,000 U/mL |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | CA-242 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Xiang M, Ma TM, Savjani R, Pollom EL, Karnes RJ, Grogan T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Huland H, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Alam R, Schwen Z, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Chong N, Kupelian PA, Rettig MB, Zaorsky NG, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Tilki D, Czernin J, Gafita A, Romero T, Calais J, Kishan AU. Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer JAMA Netw Open. 2021 Dec 1;4(12):e2138550.
- Song W, Tiruthani K, Wang Y, Shen L, Hu M, Dorosheva O, Qiu K, Kinghorn KA, Liu R, Huang L. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis Adv Mater. 2018 Dec;30(52):e1805007.
- Anagnostou T, Riaz IB, Hashmi SK, Murad MH, Kenderian SS. Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis Lancet Haematol. 2020 Nov;7(11):e816-e826.
- Li CJ, Lin LT, Hou MF, Chu PY. PDL1/PD1 blockade in breast cancer: The immunotherapy era (Review) Oncol Rep. 2021 Jan;45(1):5-12.
- Palmqvist R, Engars B, Lindmark G, Hallmans G, Tavelin B, Nilsson O, Hammarstrm S, Hafstrm L. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study Dis Colon Rectum. 2003 Nov;46(11):1538-44.
- Yang XQ, Chen C, Peng CW, Liu SP, Li Y. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases Med Oncol. 2012 Jun;29(2):1030-6.
- Li X, Guo X, Li H, Lin H, Sun Y. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer Tumour Biol. 2014 Jun;35(6):5281-6.
- Carpelan-Holmstrm MA, Haglund CH, Roberts PJ. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen Dis Colon Rectum. 1996 Jul;39(7):799-805.
- Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttil I, Alhava E. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score Br J Cancer. 1994 Mar;69(3):562-5.
